icosapent

Drug ingredient

CAS 10417-94-4

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 10417-94-4
US productionNot reported
Import value, 2024$117M
Top sourceChina 50%

This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.

Why supply is unknown

Production is reported production, not a complete census of factories. Import value and source-country shares describe a shared customs category, not a separate chemical measurement.

Where It Comes From

Customs basis: HS 291619 · basket

These shares come from HS customs code 291619, which covers 169 tracked chemicals in total. They estimate the category's origin mix, not this chemical specifically.

Source Countries
CN 50%ChinaDE 21%GermanyTW 12%TaiwanIN 7%IndiaGB 3%United Kingdom
5 FDA-registered drug labelers
Acella Pharmaceuticals, LLC
Avion Pharmaceuticals, LLC
CarWin Pharmaceutical Associates, LLC
Catalent Pharma Solutions, LLC
Prodose, Inc

Why It Matters

Sectors
Health
Downstream Uses

Appears in 4 drug and cosmetic product listings (FDA).

  • •PNV-Omega
  • •TriStart DHA
  • •Prenate Essential
  • •BP Vit 3
FDA Shortage Status
No Shortage
Shortage History
  • to be discontinued

    Icosapent Ethyl Capsule

    Shortage listed since April 1, 2026

See all current drug shortages

Chemical Identity

CAS10417-94-4
PubChem CID446284
DTXSIDDTXSID9041023
FormulaC20H30O2
Mol. Weight302.5 g/mol
SMILESCCC=CCC=CCC=CCC=CCC=CCCCC(=O)O

Data Sources

Brief citations

icosapent (CAS 10417-94-4) https://chemicalindependence.com/chemical/10417-94-4/ PubChem: 446284. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/446284 FDA National Drug Code directory: CAS 10417-94-4. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA Drug Shortages: CAS 10417-94-4. Retrieved 2026-10-04. https://www.accessdata.fda.gov/scripts/drugshortages/ US Census international trade: HS 291619 for CAS 10417-94-4. Reporting year: 2024. https://usatrade.census.gov/